Hepatitis B and Hepatitis C Viral Infections and Associated Factors Among Prisoners in Northeast Ethiopia

References

• World Health Organization [WHO]. Global health sector strategy on viral hepatitis. Towards ending viral hepatitis. In: Global Hepatitis Programme Department of HIV/AIDS; 2016–2021.
   Google Scholar
• World Health Organization. Global Hepatitis Report 2017; 2017 Licence: CC BY-NC-SA 3.0 IGO. Geneva: World Health Organization. 2017.
   Google Scholar
• Blach S, Zeuzem S, Manns M, et al. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2:3.
   Web of Science ®Google Scholar
• World Health Organization. Hepatitis C [Internet]. WHO; 2020. Accessed https://www.who.int/news-room/fact-sheets/detail/hepatitis-c. 2020 Nov 14.
   Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:9859.
   Web of Science ®Google Scholar
• Perz JF, Armstrong GL, Farrington LA, Hutin YJF, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45:4.
   Web of Science ®Google Scholar
• Cox AL, El-Sayed MH, Kao JH, et al. Progress towards elimination goals for viral hepatitis. Nat Rev Gastroenterol Hepatol. 2020;17:9.
   Web of Science ®Google Scholar
• Taherkhani R, Farshadpour F. Global elimination of hepatitis C virus infection: progresses and the remaining challenges. World J Hepatol. 2017;9:1239–1252.
   Web of Science ®Google Scholar
• Taherkhani R, Farshadpour F. Lurking epidemic of hepatitis C virus infection in Iran: a call to action. World J Hepatol. 2017;9(24):1040–1042.
   Web of Science ®Google Scholar
• WHO. Hepatitis B [Internet]. Fact Sheets. 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. Accessed May 31, 2021.
   Google Scholar
• WHO. Hepatitis C [Internet]. Fact Sheets. 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c. Accessed May 25, 2021.
   Google Scholar
• De La Hoya PS, Marco A, García-Guerrero J, Rivera A. Hepatitis c and b prevalence in Spanish prisons. Eur J Clin Microbiol Infect Dis. 2011;30:7.
   Web of Science ®Google Scholar
• Kamarulzaman A, Reid SE, Schwitters A, et al. Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners. The Lancet. 2016;388.
   Web of Science ®Google Scholar
• Dolan K, Wirtz AL, Moazen B, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. The Lancet. 2016;388.
   Web of Science ®Google Scholar
• Behzadifar M, Gorji HA, Rezapour A, Bragazzi NL. Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysis. Harm Reduct J. 2018;15.
   Web of Science ®Google Scholar
• Mohamed HI, Saad ZM, Abd-Elreheem EM, et al. Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases. J Infect Public Health. 2013;6:3.
   Web of Science ®Google Scholar
• Kose S, Adar P, Gozaydin A, Kuzucu L, Akkoclu G. Hepatitis B and Hepatitis C in prisons: a prevalence study. Int J Prison Health. 2019;15:2.
   Web of Science ®Google Scholar
• Larney S, Kopinski H, Beckwith CG, et al. Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology. 2013;58:4.
   Web of Science ®Google Scholar
• El Maerrawi I, Carvalho HB. Prevalence and risk factors associated with HIV infection, hepatitis and syphilis in a state prison of São Paulo. Int J STD AIDS. 2015;26:2.
   Web of Science ®Google Scholar
• Miller ER, Bi P, Ryan P. The prevalence of HCV antibody in South Australian prisoners. J Infect. 2006;53:2.
   Web of Science ®Google Scholar
• Masarone M, Caruso R, Aglitti A, et al. Hepatitis C virus infection in jail: difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program. Dig Liver Dis. 2020;52:5.
   Google Scholar
• Belaunzarán-Zamudio PF, Mosqueda-Gomez JL, Macias-Hernandez A, Sierra-Madero JG, Ahmed S, Beyrer C. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico. PLoS One. 2017;12(6):e0179931–e0179931.
   Web of Science ®Google Scholar
• Bautista-Arredondo S, González A, Servan-Mori E, et al. A cross-sectional study of prisoners in Mexico city comparing prevalence of transmissible infections and chronic diseases with that in the general population. PLoS One. 2015;10:7.
   Web of Science ®Google Scholar
• Gidding HF, Mahajan D, Reekie J, Lloyd AR, Dwyer DE, Butler T. Hepatitis B immunity in Australia: a comparison of national and prisoner population serosurveys. Epidemiol Infect. 2015;143:13.
   Web of Science ®Google Scholar
• Moradi G, Goodarzi E, Khazaei Z. Prevalence of Hepatitis B and C in prisons worldwide: a meta-analysis during the years 2005-2015. Biomed Res Ther. 2018;5:4.
   Web of Science ®Google Scholar
• Walmsley R. World Prison Population List (twelfth edition). Inst Crim Policy Res. 2018;12.
   Google Scholar
• Kebede W, Abdissa A, Seid Y, Mekonnen Z. Seroprevalence and risk factors of hepatitis B, hepatitis C and HIV infections among prisoners in Jimma Town, Southwest Ethiopia. Asian Pacific J Trop Dis. 2017;7:5.
   Google Scholar
• Berhe H, Yismaw G, Addis Z, Anagaw H, Uc B. Seroprevalence and associated risk factors of human immunodeficiency virus and Hepatitis B Virus infections among prison inmates. J Pharm Biomed Sci. 2013;30(30):1035–1045.
   Google Scholar
• Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35.
   Google Scholar
• Elfil M, Negida A. Sampling methods in clinical research; an educational review. Arch Acad Emerg Med. 2019;7:1.
   Google Scholar
• Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003).
   Google Scholar
• Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57:4.
   Web of Science ®Google Scholar
• Zampino R, Coppola N, Di Caprio G, Sagnelli C, Sagnelli E. Hepatitis C virus infection and prisoners: epidemiology, outcome and treatment. World J Hepatol. 2015;7.
   Google Scholar
• Ramamoorthy M, Venketeswaran A, Seenivasan P, et al. Risk factors and prevalence, hepatitis B virus and hepatitis C virus among prison inmates, Chennai, India, 2015. Int J Infect Dis. 2016;53.
   Web of Science ®Google Scholar
• Gétaz L, Casillas A, Siegrist CA, et al. Hepatitis B prevalence, risk factors, infection awareness and disease knowledge among inmates: a cross-sectional study in Switzerland’s largest pre-trial prison. J Glob Health. 2018;8:2.
   Web of Science ®Google Scholar
• Crowley D, Lambert JS, Betts-Symonds G, et al. The seroprevalence of untreated chronic hepatitis c virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017. Eurosurveillance. 2019;24:14.
   Web of Science ®Google Scholar
• Jaquet A, Wandeler G, Tine J, et al. HIV infection, viral hepatitis and liver fibrosis among prison inmates in West Africa. BMC Infect Dis. 2016;16:1.
   Web of Science ®Google Scholar
• Dan-Nwafor C, Adeoye I, Aderemi K, et al. Knowledge, serological markers and risk factors associated with Hepatitis B and C virus infection among Kuje Prison Inmates, Federal Capital Territory, Nigeria. Int J Infect Dis. 2018;73.
   Web of Science ®Google Scholar
• Taleban R, Moafi M, Ataei B, et al. Seroprevalence of Hepatitis B infection and associated risk factors among drug users in drop-in centers of Isfahan, Iran. Int J Prev Med. 2018;9.
   Web of Science ®Google Scholar
• Belaunzaran-Zamudio PF, Mosqueda-Gomez JL, MacIas-Hernandez A, Rodríguez-Ramírez S, Sierra-Madero J, Beyrer C. Burden of HIV, Syphilis, and Hepatitis B and C among Inmates in a Prison State System in Mexico. AIDS Res Hum Retroviruses. 2017;33.
   Web of Science ®Google Scholar
• Ghafari S, Sharifzadeh G, Jamali S, Taji B, Javadmoosavi SY, Ziaee M. Prevalence of Hepatitis B and C among drug-abusing male prisoners in Birjand, South Khorasan, Iran. Arch Iran Med. 2019;22:9.
   Web of Science ®Google Scholar
• Sunbul M. Hepatitis B virus genotypes: global distribution and clinical importance. World J Gastroenterol. 2014;20:18.
   Web of Science ®Google Scholar
• Alvarez KJ, Befus M, Herzig CTA, Larson E. Prevalence and correlates of hepatitis C virus infection among inmates at two New York State correctional facilities. J Infect Public Health. 2014;7:6.
   Web of Science ®Google Scholar
• Moradi G, Gouya MM, Azimizan Zavareh F, et al. Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio-behavioural surveillance survey in 2015. Trop Med Int Heal. 2018;23:6.
   Web of Science ®Google Scholar
• Overs C. booshtee! Survival and resilience in Ethiopia. Inst Dev Stud. 2015.
   Google Scholar
• FDRE. The Criminal Code of the Federal Democratic Republic of Ethiopia. Negarita Gazeta. 414. 2004.
   Google Scholar
• Tadele G, Amde WK. Health needs, health care seeking behaviour, and utilization of health services among lesbians, gays and bisexuals in Addis Ababa, Ethiopia. Int J Equity Health. 2019;18:1.
   Web of Science ®Google Scholar
• Meka IA, Onodugo OD, Obienu O, Okite J. Hepatitis B surface antigenemia in two rural communities in Enugu, Nigeria. Niger J Clin Pract. 2019;22:7.
   Web of Science ®Google Scholar
• Lingani M, Akita T, Ouoba S, et al. High prevalence of hepatitis B infections in Burkina Faso (1996-2017): a systematic review with meta-analysis of epidemiological studies. BMC Public Health. 2018;18.
   Web of Science ®Google Scholar
• Andriamandimby SF, Olive MM, Shimakawa Y, et al. Prevalence of chronic hepatitis B virus infection and infrastructure for its diagnosis in Madagascar: implication for the WHO’s elimination strategy. BMC Public Health. 2017;17:1.
   Web of Science ®Google Scholar
• Rey I, Saragih RH, Effendi-Ys R, Sembiring J, Siregar GA, Zain LH Profile of hepatitis B and C virus infection in prisoners in Lubuk Pakam correctional facilities. In: IOP Conference Series: Earth and Environmental Science. 2018.
   Google Scholar
• Kinner SA, Snow K, Wirtz AL, Altice FL, Beyrer C, Dolan K. Age-specific global prevalence of Hepatitis B, Hepatitis C, HIV, and tuberculosis among incarcerated people: a systematic review. J Adolescent Health. 2018;62.
   Web of Science ®Google Scholar
• Søholm J, Holm DK, Mössner B, et al. Incidence, prevalence and risk factors for hepatitis C in Danish prisons. PLoS One. 2019;14:7.
   Web of Science ®Google Scholar
• Puga MAM, Bandeira LM, Pompilio MA, et al. Prevalence and incidence of HCV infection among prisoners in Central Brazil. PLoS One. 2017;12:1.
   Web of Science ®Google Scholar
• Guimarães T, Granato CF, Varella D, Ferraz ML, Castelo A, Kallás EG. High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection. Braz J Infect Dis. 2001;5:3.
   Google Scholar
• Taye BW. A path to ending hepatitis C in Ethiopia: a phased public health approach to achieve micro-elimination. Am J Trop Med Hygiene. 2019;101.
   Web of Science ®Google Scholar
• Al-Kubaisy W, Al-Naggar RA, Shamsidah NIN, Bobryshev YV, Al-Kubaisy MW. Is dental extraction a risk factor for contracting HCV infection: abs, RNA and genotype detection. Oral Biol Dent. 2014;2:1.
   Google Scholar
• Shiferaw F, Letebo M, Bane A. Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia. BMC Public Health. 2016;16:1.
   Web of Science ®Google Scholar
• World Medical Association declaration of Helsinki.:Ethical principles for medical research involving human subjects. JAMA. 2013;310.
   Web of Science ®Google Scholar